Page last updated: 2024-10-22

alendronate and Paraplegia

alendronate has been researched along with Paraplegia in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.

Research Excerpts

ExcerptRelevanceReference
"Alendronate and calcium were generally safe and well tolerated."2.71Prevention of bone loss in paraplegics over 2 years with alendronate. ( Knecht, H; Kraenzlin, M; Lippuner, K; Michel, D; Perrelet, R; Risi, S; Zäch, GA; Zehnder, Y, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zehnder, Y1
Risi, S1
Michel, D1
Knecht, H1
Perrelet, R1
Kraenzlin, M1
Zäch, GA1
Lippuner, K1

Trials

1 trial available for alendronate and Paraplegia

ArticleYear
Prevention of bone loss in paraplegics over 2 years with alendronate.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:7

    Topics: Adult; Alendronate; Amino Acids; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Creatinine

2004